Medicare Enrolled
Dr. Cathy Criss, DO
Family Medicine · Port Charlotte, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Criss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Criss? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Criss
Dr. Cathy Criss is a family medicine in Port Charlotte, FL, with 20 years in practice. Based on federal Medicare data, Dr. Criss performed 21,001 Medicare services across 10,543 unique beneficiaries.
Between the years covered by Open Payments, Dr. Criss received a total of $8,105 from 50 pharmaceutical and/or device companies across 419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Criss is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $8,105 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,001
Medicare services
Top 1% in FL for family medicine
10,543
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,050 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,042 | $18 | $47 |
| Office visit, established patient (30-39 min) | 1,677 | $85 | $264 |
| Blood draw (venipuncture) | 1,576 | $8 | $17 |
| Complete blood count (CBC) with differential | 1,380 | $8 | $16 |
| Comprehensive metabolic blood panel | 1,376 | $10 | $21 |
| Lipid panel (cholesterol and triglycerides) | 1,298 | $13 | $27 |
| Creatine kinase (cardiac enzyme) level, total | 1,139 | $6 | $13 |
| Hemoglobin A1c test (diabetes monitoring) | 836 | $9 | $19 |
| Thyroid stimulating hormone (TSH) test | 783 | $16 | $34 |
| Free thyroxine (T4) test | 779 | $9 | $18 |
| Thyroid hormone, t3 measurement, total | 775 | $14 | $28 |
| Vitamin D level test | 724 | $29 | $59 |
| Annual wellness visit, follow-up | 531 | $125 | $267 |
| Annual depression screening | 500 | $18 | $38 |
| Urine microalbumin test (kidney screening) | 414 | $6 | $12 |
| Creatinine test (kidney function) | 414 | $5 | $10 |
| Automated urinalysis | 373 | $2 | $4 |
| Magnesium level test | 354 | $7 | $13 |
| Phosphate level test | 332 | $5 | $9 |
| Parathyroid hormone level test | 305 | $40 | $83 |
| Prothrombin time test (blood clotting) | 298 | $4 | $9 |
| Urinalysis with microscopic exam | 297 | $3 | $6 |
| Electrocardiogram (EKG), 12-lead | 248 | $10 | $30 |
| Urine culture, bacterial colony count | 179 | $8 | $16 |
| Uric acid level test | 170 | $4 | $9 |
| Vitamin B-12 level test | 156 | $15 | $30 |
| Flu vaccine administration | 136 | $30 | $64 |
| Ferritin level test (iron stores) | 125 | $13 | $27 |
| Iron level test | 122 | $6 | $13 |
| Iron binding capacity test | 117 | $9 | $17 |
| Drug injection, under skin or into muscle | 99 | $10 | $31 |
| Flu vaccine, high-dose | 91 | $71 | $145 |
| PSA test (prostate cancer screening) | 73 | $17 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 73 | $40 | $107 |
| Measurement of total estradiol (hormone) | 72 | $27 | $56 |
| Bacterial culture, aerobic | 71 | $8 | $16 |
| Antibiotic sensitivity test | 71 | $8 | $17 |
| C-reactive protein test (inflammation marker) | 66 | $5 | $10 |
| Testosterone (hormone) level, total | 65 | $25 | $52 |
| Sed rate test (inflammation marker) | 62 | $3 | $5 |
| Prostate cancer screening; prostate specific antigen test (psa) | 60 | $19 | $39 |
| Cortisol (hormone) measurement, total | 51 | $16 | $33 |
| Folic acid level test | 51 | $14 | $29 |
| Dehydroepiandrosterone (dhea-s) hormone level | 50 | $22 | $44 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 44 | $47 | $132 |
| Pneumonia vaccine administration | 35 | $30 | $64 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 34 | $282 | $576 |
| Office visit, established patient (20-29 min) | 34 | $59 | $187 |
| Office visit, established patient, complex (40-54 min) | 34 | $130 | $371 |
| Flu vaccine, quadrivalent | 33 | $76 | $149 |
| Transitional care management services for problem of at least moderate complexity | 32 | $143 | $420 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 28 | $18 | $37 |
| Gonadotropin, luteinizing (reproductive hormone) level | 28 | $18 | $37 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 28 | $1 | $3 |
| Blood creatinine level | 27 | $5 | $10 |
| New patient office visit (45-59 min) | 24 | $87 | $347 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 23 | $28 | $86 |
| Basic metabolic blood panel | 22 | $8 | $17 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 22 | $45 | $93 |
| Urinalysis, manual | 21 | $3 | $7 |
| Albumin (protein) level | 20 | $5 | $10 |
| Removal of impacted ear wax by washing | 18 | $14 | $32 |
| Psa (prostate specific antigen) measurement, free | 18 | $16 | $37 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 18 | $65 | $144 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 18 | $162 | $343 |
| Transitional care management services for problem of high complexity | 17 | $168 | $570 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 12 | $5 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
10.3% medium
89.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,105
Total received (2018-2024)
Avg $1,158/year across 7 years
Top 6% in FL for family medicine
50
Companies
419
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,594 (93.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$511 (6.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,731
2023$1,146
2022$904
2021$746
2020$742
2019$1,731
2018$1,105
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,854
PFIZER INC.
$679
GlaxoSmithKline, LLC.
$644
Amgen Inc.
$567
Astellas Pharma US Inc
$562
Esperion Therapeutics, Inc.
$544
Lilly USA, LLC
$534
ABBVIE INC.
$395
Novo Nordisk Inc
$352
AbbVie Inc.
$227
AstraZeneca Pharmaceuticals LP
$163
Novartis Pharmaceuticals Corporation
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
Radius Health, Inc.
$132
Takeda Pharmaceuticals U.S.A., Inc.
$99
Avanir Pharmaceuticals, Inc.
$68
Boston Scientific Corporation
$68
IDORSIA PHARMACEUTICALS US INC
$63
ABIOMED
$51
Amarin Pharma Inc.
$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$44
Aytu BioScience, Inc
$44
Exeltis, USA Inc.
$41
Phadia US Inc.
$38
Abbott Laboratories
$37
Merck Sharp & Dohme Corporation
$36
LIFESCAN, INC.
$35
Nevro Corp.
$34
GE HEALTHCARE
$31
Teva Pharmaceuticals USA, Inc.
$31
Biohaven Pharmaceutical Holding Company Ltd.
$29
Lundbeck LLC
$28
Shire North American Group Inc
$27
Biohaven Pharmaceuticals, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$24
E.R. Squibb & Sons, L.L.C.
$23
Zyla Life Sciences
$22
AbbVie, Inc.
$22
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
OptiNose US, Inc.
$18
Mannkind Corporation
$18
Genentech USA, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Eisai Inc.
$16
Noden Pharma USA Inc
$16
Merck Sharp & Dohme LLC
$15
Azurity Pharmaceuticals, Inc.
$13
Circassia Pharmaceuticals Inc
$12
Kowa Pharmaceuticals America, Inc.
$11
KVK-Tech, Inc.
$10
Top 3 companies account for 39.2% of total payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Adthyza · Aimovig · BASAGLAR · Belviq · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Creon · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLECTOR · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GLASSIA · INVOKANA · ImmunoCAP · Impella · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LYRICA · LifeVest · Livalo · MOUNJARO · MYFEMBREE · MYRBETRIQ · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Natesto · ONETOUCH VERIO FLEX · ONZETRA Xsail · Otezla · Ozempic · PAXLOVID · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SLYND · SOLIQUA · SPRIX · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Senza · TEKTURNA · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Trintellix · Tymlos · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Veozah · WATCHMAN FLX · XARELTO · XIFAXAN · Xhance · Xofluza · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in FL.
Equivalent to $39 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
167
Per 100K population
85.6
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Criss is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 6%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Criss experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Criss performed 2,042 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Criss receive payments from pharmaceutical companies?
Yes. Dr. Criss received a total of $8,105 from 50 companies across 419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Criss's costs compare to other family medicines in Port Charlotte?
Dr. Criss's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Criss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Port Charlotte
Browse family medicines in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology